Patents by Inventor Magdalena Izabela ZAWADZKA

Magdalena Izabela ZAWADZKA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Modulators of stimulator of interferon genes (STING)
    Patent number: 12162863
    Abstract: The present invention relates to compounds of formula (I) and salts, stereoisomers, tautomers or N-oxides thereof that are useful as modulators of STING (Stimulator of Interferon Genes). The present invention further relates to the compounds of formula (I) for use as a medicament and to a pharmaceutical composition comprising said compounds.
    Type: Grant
    Filed: June 12, 2019
    Date of Patent: December 10, 2024
    Assignee: RYVU THERAPEUTICS S.A.
    Inventors: Monika Patrycja Dobrzanska, Magdalena Izabela Zawadzka, Adam Radzimierski, Grzegorz Witold Topolnicki, Grzegorz Wojciech Cwiertnia, Tushar Ravindra Mahajan, Charles-Henry Fabritius, Stefan Chmielewski, Karolina Maria Gluza, Jose Alvarez, Maciej Krzysztof Rogacki, Magdalena Mroczkowska
  • HETEROCYCLIC COMPOUNDS AS MODULATORS OF STIMULATOR OF INTERFERON GENES (STING)
    Publication number: 20230076506
    Abstract: The present invention relates to compounds of formula (I) and salts, stereoisomers, tautomers or N-oxides thereof that are useful as modulators of STING (Stimulator of Interferon Genes). The present invention further relates to the compounds of formula (I) for use as a medicament and to a pharmaceutical composition comprising said compounds.
    Type: Application
    Filed: December 11, 2020
    Publication date: March 9, 2023
    Applicant: RYVU THERAPEUTICS S.A.
    Inventors: Magdalena Izabela ZAWADZKA, Luigi Piero STASI, Maciej Krzysztof ROGACKI, Grzegorz Wojciech CWIERTNIA, Lukasz Piotr DUDEK, Agnieszka Justyna GIBAS, Anna RAJDA, Charles-Henry FABRITIUS, Adam RADZIMIERSKI, Tushar Ravindra MAHAJAN, Marcin Wojciech LES, Karol ZUCHOWICZ, Marek WRONOWSKI, David Jörg SYNAK, Sundara Raghuram TANGIRALA
  • FUNCTIONALIZED HETEROCYCLIC COMPOUNDS AS MODULATORS OF STIMULATOR OF INTERFERON GENES (STING)
    Publication number: 20230055741
    Abstract: The present invention relates to compound-linker constructs and antibody-drug-conjugates of compounds of formula (I) that are useful as modulators of STING (Stimulator of Interferon Genes).
    Type: Application
    Filed: December 11, 2020
    Publication date: February 23, 2023
    Applicant: RYVU THERAPEUTICS S.A.
    Inventors: Magdalena Izabela ZAWADZKA, Luigi Piero STASI, Maciej Krzysztof ROGACKI, Grzegorz Wojciech CWIERTNIA, Lukasz Piotr DUDEK, Agnieszka Justyna GIBAS, Anna RAJDA, Charles-Henry FABRITIUS, Adam RADZIMIERSKI, Tushar Ravindra MAHAJAN, Marcin Wojciech LES, Karol ZUCHOWICZ, Marek WRONOWSKI, David Jörg SYNAK, Sundara Raghuram TANGIRALA
  • MODULATORS OF STIMULATOR OF INTERFERON GENES (STING)
    Publication number: 20220402898
    Abstract: The present invention relates to compounds of formula (I) and salts, stereoisomers, tautomers or N-oxides thereof that are useful as modulators of STING (Stimulator of Interferon Genes). The present invention further relates to the compounds of formula (I) for use as a medicament and to a pharmaceutical composition comprising said compounds.
    Type: Application
    Filed: June 12, 2019
    Publication date: December 22, 2022
    Applicant: RYVU THERAPEUTICS S.A.
    Inventors: Monika Patrycja DOBRZANSKA, Magdalena Izabela ZAWADZKA, Adam RADZIMIERSKI, Grzegorz Witold TOPOLNICKI, Grzegorz Wojciech CWIERTNIA, Tushar Ravindra MAHAJAN, Charles-Henry FABRITIUS, Stefan CHMIELEWKSI, Karolina Maria GLUZA, Jose ALVAREZ, Maciej Krzysztof ROGACKI, Magdalena MROCZKOWSKA
  • NEXT-GENERATION MODULATORS OF STIMULATOR OF INTERFERON GENES (STING)
    Publication number: 20220251082
    Abstract: The present invention relates to compounds of formula (I) and salts, stereoisomers, tautomers or N-oxides thereof that are useful as modulators of STING (Stimulator of Interferon Genes). The present invention further relates to the compounds of formula (I) for use as a medicament and to a pharmaceutical composition comprising said compounds.
    Type: Application
    Filed: June 12, 2020
    Publication date: August 11, 2022
    Applicant: RYVU THERAPEUTICS S.A.
    Inventors: Magdalena Izabela ZAWADZKA, Luigi Piero STASI, Maciej Krzysztof ROGACKI, Grzegorz Wojciech CWIERTNIA, Lukasz Piotr DUDEK, Monika Patrycja DOBRZANSKA, Grzegorz Witold TOPOLNICKI, Agnieszka Justyna GIBAS, Anna RAJDA, Sylwia SUDOL, Karolina Maria GLUZA, Charles-Henry FABRITIUS